Close Menu

NEW YORK – NantHealth said Thursday after the close of the market that its second quarter revenues declined 12 percent to $17.6 million from $20.1 million in Q2 2019

The Culver City, California-based company had total software-related revenues of $17.5 million, down 4 percent from $18.3 million in Q2 2019. All software-related revenues now come from software-as-a-service (SaaS) offerings.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

AstraZeneca has released its coronavirus vaccine trial protocol, according to the New York Times.

Time magazine looks into how liquid biopsies are changing cancer care.

According to the Guardian, more than 150 countries have signed on to a global SARS-CoV-2 vaccine plan.

In PNAS this week: similar muscle protein patterns across hypertrophic cardiomyopathy phenotypes, analysis of gene expression and brain anatomy in major depression, and more.